Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-18-268219
Filing Date
2018-09-06
Accepted
2018-09-06 16:03:03
Documents
8
Effectiveness Date
2018-09-06

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR d618063ds3asr.htm S-3ASR 309396
2 EX-4.6 d618063dex46.htm EX-4.6 83263
3 EX-4.7 d618063dex47.htm EX-4.7 292051
4 EX-5.1 d618063dex51.htm EX-5.1 25092
5 EX-12.1 d618063dex121.htm EX-12.1 22153
6 EX-23.1 d618063dex231.htm EX-23.1 1696
7 GRAPHIC g618063g85f37_268.jpg GRAPHIC 44219
8 GRAPHIC g618063page110.jpg GRAPHIC 3205
  Complete submission text file 0001193125-18-268219.txt   800321
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-227209 | Film No.: 181057578
SIC: 2834 Pharmaceutical Preparations